Back to Search
Start Over
"Ungulate-Derived Polyclonal Immunoglobulin Specific For Influenza Virus And Uses Thereof" in Patent Application Approval Process (USPTO 20240279315).
- Source :
- Clinical Trials Week; 9/9/2024, p805-805, 1p
- Publication Year :
- 2024
-
Abstract
- The article discusses a patent application for an ungulate-derived polyclonal immunoglobulin specific for influenza virus, filed on February 16, 2024. Topics include the development of this immunoglobulin from transchromosomic bovines, its potential therapeutic uses, and the challenges associated with influenza virus mutations.
Details
- Language :
- English
- ISSN :
- 15436772
- Database :
- Complementary Index
- Journal :
- Clinical Trials Week
- Publication Type :
- Periodical
- Accession number :
- 179479038